ANI Pharma Guides FY23 Adj. EPS Below Estimates, But Revenues Above - Update

RTTNews | 805 dias atrás
ANI Pharma Guides FY23 Adj. EPS Below Estimates, But Revenues Above - Update

(RTTNews) - While reporting financial results for the fourth quarter on Thursday, biopharmaceutical company ANI Pharmaceuticals, Inc. (ANIP) initiates adjusted earnings and net revenue guidance for the full-year 2023.

For fiscal 2023, the company now projects adjusted earnings in a range of $2.09 to $2.59 per share on net revenues between $360 million and $385 million, with purified cortrophin gel revenue at $80 million to $90 million.

On average, analysts polled by Thomson Reuters expect the company to report earnings of $2.62 per share on revenues of $352.49 million for the year. Analysts' estimates typically exclude special items.

For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com

Marcadores : ANIP ANIP,
read more
Walmart To Cut 1,500 Corporate Jobs In Cost-cutting Efforts

Walmart To Cut 1,500 Corporate Jobs In Cost-cutting Efforts

Amid a challenging retail environment, due to fierce competition along with ongoing tariff issues, retail behemoth Walmart Inc. is planning to cut around 1,500 corporate jobs in the United States as part of its restructuring, media reported citing a memo. The multinational chain of hypermarkets, discount department stores, and grocery stores' efforts to simplify its operations...
RTTNews | 18 minutos atrás
German Ifo Business Sentiment Strengthens; Composite PMI Falls

German Ifo Business Sentiment Strengthens; Composite PMI Falls

German business confidence strengthened in May as companies became less concerned about uncertainties regarding trade tariffs, a closely watched survey showed Thursday. The Purchasing Managers' survey compiled by S&P Global today showed that the German private sector activity contracted the most in five months in May due to a deepening downturn in the service sector.
RTTNews | 20 minutos atrás